5
Orphan Designations
0
FDA Approvals
9
Rare Diseases
0
News Articles
| Disease | Drug(s) | Designation | Approved |
|---|---|---|---|
| Finnish type amyloidosis | Imiquimod | Orphan Designation | - |
| T lymphoblastic leukemia/lymphoma | imiquimod-ferulic acid | Orphan Designation | - |
| childhood precursor T-lymphoblastic lymphoma/leukemia | imiquimod-ferulic acid | Orphan Designation | - |
| cutaneous leishmaniasis | Imiquimod-Ferulic Acid | Orphan Designation | - |
| malignant glioma | imiquimod-ferulic acid | Orphan Designation | - |
| refractory precursor T-lymphoblastic lymphoma/leukemia | imiquimod-ferulic acid | Orphan Designation | - |
| stage II endometrioid carcinoma | Imiquimod | Orphan Designation | - |
| stage IVb bladder cancer | Imiquimod | Orphan Designation | - |
| vulvar intraepithelial neoplasia | imiquimod (IMQ)-ferulic acid (FA) co-crystal (IMQ API and FA coformer) | Orphan Designation | - |